Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 16, 2025
Pathological forms of TDP-43 in amyotrophic lateral sclerosis (ALS) promote aberrant telomere elongationAnna Konopka, Md Shafi Jamali, Megan Fowler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2008
Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian communityPrachi Mehta, George D Mellick, Dominic B Rowe, et al.
Brain : a Journal of Neurology|March 10, 2026
Cofilin hyperphosphorylation triggers TDP-43 pathology in sporadic amyotrophic lateral sclerosisCyril Jones Jagaraj, Sayanthooran Saravanabavan, Sonam Parakh, et al.
The European Journal of Neuroscience|August 14, 2021
Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosisAmanda L Wright, Paul A Della Gatta, Sheng Le, et al.
Scientific Reports|November 22, 2023
ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentationAudrey M G Ragagnin, Vinod Sundaramoorthy, Fabiha Farzana, et al.
Molecular Neurodegeneration|September 10, 2020
Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutationsAnna Konopka, Donna R Whelan, Md Shafi Jamali, et al.
Nature Communications|February 19, 2024
A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegenerationRebecca San Gil, Dana Pascovici, Juliana Venturato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 7, 2019
Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 miceEmily P McCann, Jennifer A Fifita, Natalie Grima, et al.
Pageof 3